Navigation Links
Promising new treatment option for women with recurrent ovarian cancer
Date:9/15/2008

Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

The combination, which importantly does not include a platinum drug, challenges the current standard of treatment for women whose cancer recurs at least 6 months after first-line treatment, said Associate Prof. Bradley J. Monk from the University of California Irvine Medical Center.

"This trial, which included almost two-thirds such women, challenges this traditional paradigm and suggests that a non-platinum doublet is also effective in this setting," he said. "Trabectedin represents a 'new chemical entity' in North America and if approved by the FDA, would be an important new option for women with recurrent ovarian cancer."

Trabectedin, a synthetic version of a compound first isolated from sea-squirts, has been granted marketing approval in Europe for the treatment of patients with advanced soft tissue sarcoma.

In the latest trial, an international group of researchers studied the combination in 672 women whose ovarian cancer had progressed after first-line therapy. Half the women received pegylated liposomal doxorubicin 30 mg/m2 over 60 min plus trabectedin 1.1mg/m2 over 3 hours every 3 weeks, the remainder received pegylated liposomal doxorubicin 50 mg/m2 alone every 4 weeks.

The median length of progression-free survival for women on the combination therapy was 7.3 months, the researchers found, compared to 5.8 months for those treated with the single drug. For those who had relapsed more than six months after the first-line therapy, the median progression-free survival time was 9.2 months for the combination treatment, compared to 7.5 months for patients in the other arm.

"This drug appears active in all sub-groups included in the trial, but lik
'/>"/>

Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. UIC researchers find promising new targets for antibiotics
2. New book defines promising young field of adult neurogenesis
3. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
4. Cancer and arthritis therapy may be promising treatment for diabetes
5. Unique whey protein is promising supplement for strict PKU diet
6. Promising new drug targets identified for Huntingtons disease
7. Promising new nanotechnology for spinal cord injury
8. Biodesigns Rittmann offers promising perspectives on societys energy challenge
9. UIC researchers make promising finding in severe lung disease
10. New treatment approach promising for lymphoma patients in the developing world
11. Immunotherapy in high-risk pediatric sarcomas shows promising response

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...he bare essentials of life, the indispensable ingr...e on its own? Can we describe the molecular anatom... functions as a system? These are just some of the...n the European Molecular Biology Laboratory (EMBL)...io Genmica (CRG) in Barcelona, Spain, set out to a...
(Date:11/25/2009)... Institute of Technology (Caltech) have uncovered ...he fruit fly, Drosophila melanogaster . , Their...ip between the neurotransmitter dopamine and atten...scribed in the December issue of the journal Neur...t 20,000 neurons and has long been considered a po...
(Date:11/25/2009)... In addition to mammalian immune systems that besi...teriophages, viruses that kill half the bacteria o...nother class of microorganisms called archaea (fir...-sea volcanic vents) manage just fine, thank you, ...m that helps protect them from many viruses and ot...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Scientists Use Non Embryonic Stem Cells to Create Healthy Mice 52564 1Scientists Use Non Embryonic Stem Cells to Create Healthy Mice 52564 2Scientists Use Non Embryonic Stem Cells to Create Healthy Mice 52564 3Scientists Use Adult Stem Cells to Create Healthy Mice 52559 1Scientists Use Adult Stem Cells to Create Healthy Mice 52559 2Scientists Use Adult Stem Cells to Create Healthy Mice 52559 3Healthy Workplace Award Nominations Due August 3 52554 1
...ew software developed with help from the Wildlife ...to rapidly identify individual animals by creating...emote cameras. The software, described in an issu...identify the origin of tigers from confiscated ski... Research Ltd., creates a 3D model from scanned ph...
...t look at the broad genetic changes that accompany...lthough scientists have known for more than a cent...ts or animals are likely to suffer from low reprod..."inbreeding depression" occurs is still the subjec...ology , is the first to look at inbreeding depress...
...Kansas Flint Hills and access to the Konza Prairie...rchers certainly know grasslands. They,re using th...tswana and South Africa on studies of African gras...onza and other grass-dominated ecosystems around t...sity distinguished professor of biology. , The re...
Other Biology News:Tracking tigers in 3-D 2Researchers take first look at the genetic dynamics of inbreeding depression 2Researchers take first look at the genetic dynamics of inbreeding depression 3K-State biologist collaborating with researchers in Africa on grassland sustainability, biodiversity 2
(Date:11/24/2009)...ealth care employment grew by 29,000 jobs in Octo...nsistent growth during the U.S. recession. However...e, and health systems are coming closer to having ... administrators. , (Vocus...inued growing in October despite the shedding of j...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy a...tration (SFDA) has approved the,investigational ne...ect,(Nodlin), an innovative insulin formulation to...to initiate its first phase I clinical study. ,...gh blood glucose and poor,metabolism. The complica...
(Date:11/24/2009)...L , TORONTO, Nov. 24 /PRNewswire-FirstCall/ -...to Capital Inc., a leading provider of advanced la...arch and fertility clinic markets, today reported ...arter ended September 30, 2009. , , Q3 2009 Hi...ed with $1.43 million in Q3 2008, - Gross pro...
(Date:11/24/2009)...aly, November 24 Health Robotics t...oint venture with a group of selected,investors. T...rate under the,name Health Robotics Canada, Inc. a...cs, i.v. Room of the Future concept, which include...TM), i.v.SOFT(TM), and OMM(TM).,Health Robotics Ca...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...nt to help support Neurological Function Now Avail...wire/ -- Singapore-based Moleac today,launched a n...to support,patients, neurological functions. Neuro...mbination of ten all-natural ingredients. Moleac i...ogether the best of Asian,and Western medicine., ...
...Additional Approvals Globally for Dialysis and Ear...se Patients, CAMBRIDGE, Mass., March 6 Genzyme C...nch of the phosphate binder,Renvela(R) (sevelamer ...ficant progress in its international efforts to se...me has submitted a marketing authorization applica...
...to become sole U.S. supplier of 3M electrosurgical...essories, MUNDELEIN, Ill., March 6 Medline Indus...ve license and supply agreement for 3M,s,electrosu...this agreement,Medline has acquired the exclusive ...3M,s electrosurgical patient plates and accessorie...
Other Biology Technology:Moleac Launches NeuroAid10(TM) in the United States 2Moleac Launches NeuroAid10(TM) in the United States 3Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 2Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 3Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 4Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 5Medline and 3M Agree to Strategic Partnership in Electrosurgery 2Medline and 3M Agree to Strategic Partnership in Electrosurgery 3
Corning ultragaps Coated Slides,Nonbar-Coded from Sigma-Aldrich
SYBRGreen I nucleic acid gel stain from Sigma-Aldrich
PG 3000 Photographic Digital Printer from FUJIFILM Life Science
...ht® IR Mouse Cytokine Array is a multiplex sa...or the quantitative measurement of 12 cytokines in...ulture supernatants. Each well of the microplate p...ecific cytokines in standards and samples added to...
Biology Products: